Aptamer Sciences Cash And Equivalents vs. Market Capitalization

291650 Stock  KRW 1,816  73.00  3.86%   
Based on Aptamer Sciences' profitability indicators, Aptamer Sciences may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in December. Profitability indicators assess Aptamer Sciences' ability to earn profits and add value for shareholders.
For Aptamer Sciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Aptamer Sciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Aptamer Sciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Aptamer Sciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Aptamer Sciences over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between Aptamer Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aptamer Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aptamer Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Aptamer Sciences Market Capitalization vs. Cash And Equivalents Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Aptamer Sciences's current stock value. Our valuation model uses many indicators to compare Aptamer Sciences value to that of its competitors to determine the firm's financial worth.
Aptamer Sciences is number one stock in cash and equivalents category among its peers. It is rated below average in market capitalization category among its peers creating about  73.34  of Market Capitalization per Cash And Equivalents. Comparative valuation analysis is a catch-all model that can be used if you cannot value Aptamer Sciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Aptamer Sciences' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Aptamer Market Capitalization vs. Cash And Equivalents

Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

Aptamer Sciences

Cash

 = 

Bank Deposits

+

Liquidities

 = 
1.01 B
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

Aptamer Sciences

Market Cap

 = 

Shares Outstanding

X

Share Price

 = 
74.03 B
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.

Aptamer Sciences Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Aptamer Sciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Aptamer Sciences will eventually generate negative long term returns. The profitability progress is the general direction of Aptamer Sciences' change in net profit over the period of time. It can combine multiple indicators of Aptamer Sciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Aptamer Sciences, Inc., a bio venture company, focuses on the Aptamer technology platform for the development of therapeutic and diagnostic platforms. Aptamer Sciences, Inc. was founded in 2011 and is headquartered in Seongnam, South Korea. Aptamer Sciences is traded on Korean Securities Dealers Automated Quotations in South Korea.

Aptamer Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Aptamer Sciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Aptamer Sciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Aptamer Sciences' important profitability drivers and their relationship over time.

Use Aptamer Sciences in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aptamer Sciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptamer Sciences will appreciate offsetting losses from the drop in the long position's value.

Aptamer Sciences Pair Trading

Aptamer Sciences Pair Trading Analysis

The ability to find closely correlated positions to Aptamer Sciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aptamer Sciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aptamer Sciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aptamer Sciences to buy it.
The correlation of Aptamer Sciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aptamer Sciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aptamer Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aptamer Sciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Aptamer Sciences position

In addition to having Aptamer Sciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Technology Thematic Idea Now

Technology
Technology Theme
Companies that are involved in development or distribution of technologically based goods and services such as software, IT or electronics. The Technology theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Technology Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Aptamer Stock

To fully project Aptamer Sciences' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Aptamer Sciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Aptamer Sciences' income statement, its balance sheet, and the statement of cash flows.
Potential Aptamer Sciences investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Aptamer Sciences investors may work on each financial statement separately, they are all related. The changes in Aptamer Sciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Aptamer Sciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.